Jacobs Levy Equity Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,530
Closed -$220K 1108
2025
Q2
$220K Buy
+23,530
New +$259K ﹤0.01% 974
2022
Q2
Sell
-27,664
Closed -$481K 1080
2022
Q1
$481K Buy
+27,664
New +$466K ﹤0.01% 869
2020
Q2
Sell
-81,248
Closed -$891K 1143
2020
Q1
$891K Sell
81,248
-20,704
-20% -$194K 0.01% 654
2019
Q4
$895K Buy
101,952
+22,208
+28% +$163K 0.01% 707
2019
Q3
$596K Buy
79,744
+47,712
+149% +$435K 0.01% 695
2019
Q2
$298K Buy
32,032
+15,832
+98% +$115K ﹤0.01% 815
2019
Q1
$85K Sell
16,200
-26,739
-62% -$153K ﹤0.01% 937
2018
Q4
$191K Sell
42,939
-20,976
-33% -$115K ﹤0.01% 893
2018
Q3
$516K Buy
63,915
+23,100
+57% +$165K 0.01% 772
2018
Q2
$287K Buy
+40,815
New +$400K ﹤0.01% 894

Other funds holding SNDX